Corindus Vascular Robotics (Formerly known as Corindus) and Leading Interventional Cardiologists to Present Robotic Angioplasty Cases at 25th Annual TCT Meeting

Corindus Vascular Robotics, the leader in precision vascular robotics, will showcase its FDA-approved CorPath System at the upcoming Transcatheter Cardiovascular Therapeutics (TCT) 2013 annual meeting, Oct. 27 – Nov. 1 in San Francisco, CA. The CorPath is the first medical device to bring robotic precision and accuracy to coronary angioplasty to help optimize clinical outcomes.

Help employers find you! Check out all the jobs and post your resume.